These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9602696)

  • 21. Patient with late-onset Wilson's disease: deterioration with penicillamine.
    Sohtaoglu M; Ergin H; Ozekmekçi S; Gökdemir S; Sonsuz A; Arici C
    Mov Disord; 2007 Jan; 22(2):290-1. PubMed ID: 17083099
    [No Abstract]   [Full Text] [Related]  

  • 22. Epileptic status immediately after initiation of D-penicillamine therapy in a patient with Wilson's disease.
    Berger B; Mader I; Damjanovic K; Niesen WD; Stich O
    Clin Neurol Neurosurg; 2014 Dec; 127():122-4. PubMed ID: 25459257
    [No Abstract]   [Full Text] [Related]  

  • 23. Penicillamine-induced elastosis perforans serpiginosa with abnormal "lumpy-bumpy" elastic fibers in lesional and non-lesional skin.
    Khatu SS; Dhurat RS; Nayak CS; Pereira RR; Kagne RB
    Indian J Dermatol Venereol Leprol; 2011; 77(1):55-8. PubMed ID: 21220881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Penicillamine-induced degenerative dermatoses: report of a case and brief review of such dermatoses.
    Iozumi K; Nakagawa H; Tamaki K
    J Dermatol; 1997 Jul; 24(7):458-65. PubMed ID: 9267106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurologic deterioration in a child with Wilson's disease on penicillamine therapy.
    Paul AC; Varkki S; Yohannan NB; Eapen CE; Chandy G; Raghupathy P
    Indian J Gastroenterol; 2003; 22(3):104-5. PubMed ID: 12839386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Penicillamine-induced pseudo-pseudoxanthoma elasticum in a patient with rheumatoid arthritis.
    Burge S; Ryan T
    Clin Exp Dermatol; 1988 Jul; 13(4):255-8. PubMed ID: 3246093
    [No Abstract]   [Full Text] [Related]  

  • 27. Penicillamine should not be used as initial therapy in Wilson's disease.
    Brewer GJ
    Mov Disord; 1999 Jul; 14(4):551-4. PubMed ID: 10435490
    [No Abstract]   [Full Text] [Related]  

  • 28. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride.
    Walshe JM
    Q J Med; 1973 Jul; 42(167):441-52. PubMed ID: 4728043
    [No Abstract]   [Full Text] [Related]  

  • 29. Penicillamine revisited: historic overview and review of the clinical uses and cutaneous adverse effects.
    Ishak R; Abbas O
    Am J Clin Dermatol; 2013 Jun; 14(3):223-33. PubMed ID: 23605177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Penicillamine-induced elastosis of the mucosal lip.
    Lewis BK; Chern PL; Stone MS
    J Am Acad Dermatol; 2009 Apr; 60(4):700-3. PubMed ID: 19293020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Penicillamine-induced changes in elastic tissue of the upper respiratory tract.
    Manohar MB; Boldy DA; Bryan RL; Pearman K
    J Laryngol Otol; 1993 Jan; 107(1):62-4. PubMed ID: 8445321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of penicillamine-induced dermopathy.
    Tang MB; Chin TM; Yap CK; Ng SK
    Ann Acad Med Singap; 2003 Sep; 32(5):703-5. PubMed ID: 14626805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Penicillamine-induced degenerative dermopathy in a patient with Wilson's disease.
    Chen Y; Qiu Y; Chen M; Jiang Y; Qiu X; Gao L
    Australas J Dermatol; 2023 Feb; 64(1):126-130. PubMed ID: 36565232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic sclerosis-like lesions during long-term penicillamine therapy for Wilson's disease.
    Miyagawa S; Yoshioka A; Hatoko M; Okuchi T; Sakamoto K
    Br J Dermatol; 1987 Jan; 116(1):95-100. PubMed ID: 3814517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Penicillamine-induced lethal status dystonicus in a patient with Wilson's disease.
    Svetel M; Sternić N; Pejović S; Kostić VS
    Mov Disord; 2001 May; 16(3):568-9. PubMed ID: 11391761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wilson's disease.
    Walshe JM
    Lancet; 2007 Mar; 369(9565):902. PubMed ID: 17368141
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pregnancy, labor and early puerperium in a patient with Wilson's disease].
    Hlinst'ák K; Borovský M; Hlinst'áková S
    Ceska Gynekol; 1999 Jun; 64(3):198-200. PubMed ID: 10568054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential hepatotoxicity of penicillamine treatment in three patients with Wilson's disease.
    Deutscher J; Kiess W; Scheerschmidt G; Willgerodt H
    J Pediatr Gastroenterol Nutr; 1999 Nov; 29(5):628. PubMed ID: 10554138
    [No Abstract]   [Full Text] [Related]  

  • 39. [Nephrotic syndrome after treatment with d-penicillamine in a pediatric patient with Wilson's disease].
    Farallo M; Amoruso C; Frattini C; Ardissino G; Nebbia G
    Pediatr Med Chir; 2012; 34(5):234-6. PubMed ID: 23342748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Penicillamine-induced Elastosis Perforans Serpiginosa in Wilson Disease: Is Useful Switching to Zinc?
    Ranucci G; Di Dato F; Leone F; Vajro P; Spagnuolo MI; Iorio R
    J Pediatr Gastroenterol Nutr; 2017 Mar; 64(3):e72-e73. PubMed ID: 25341025
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.